New heart pill aims to keep patients out of hospital
NCT ID NCT07444398
Summary
This study is testing whether adding a drug called Vericiguat to standard heart failure treatment helps people with suddenly worsening symptoms. Researchers will compare Vericiguat against a placebo in 130 patients to see if it reduces hospital stays and deaths from heart problems over three months. The main goal is to see if this additional medication provides better control of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Armed Forces Institute of Cardiology. Pakistan
RECRUITINGRawalpindi, Punjab Province, 46000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.